Page 2 - Jeffrey Lamken News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Court concerned about scope of patent covering millions of antibodies

During oral argument in Amgen Inc. v. Sanofi on Monday, the justices explored how to write an opinion on patent enablement when the parties agree on almost everything about the legal standard. “Enablement” is the requirement that a patent must enable others to make and use the invention without un

Justice clarence thomasJustice elena kaganJeffrey lamkenMark lemleyEricm fraserJames wattPaul clementJustice neil gorsuchColleen sinzdakUs courtAmgen incFederal circuitElena kaganNeil gorsuch

Biotech outfit with eye on cholesterol drug patents grilled at Supreme Court

Biotech outfit with eye on cholesterol drug patents grilled at Supreme Court
courthousenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from courthousenews.com Daily Mail and Mail on Sunday newspapers.

United statesJeffrey lamkenSamuel morseJames wattPaul clementJustice clarence thomasFederal circuitPatent act

Supreme Court Mulls Amgen Bid to Revive Cholesterol Drug Patents

Amgen sought to convince the US Supreme Court on Monday to revive patents on its cholesterol-lowering drug Repatha, while rival Sanofi urged the justices not to stifle competition for therapies to address a common health risk.

United statesJustice ketanji brown jacksonJustice clarence thomasJoe bidenAndrew chungPaul clementJohn kruzelBlake brittainJeffrey lamkenRegeneron pharmaceuticals incUs courtUs supreme court onAmgen incRegeneron pharmaceuticalsCalifornia based amgenFederal circuit

U S Supreme Court mulls Amgen bid to revive cholesterol drug patents

WASHINGTON Amgen Inc sought to convince the U.S. Supreme Court on Monday to revive patents on its cholesterol-lowering drug Repatha, while rival Sanofi SA…

New yorkUnited statesJeffrey lamkenJoe bidenAndrew chungJustice ketanji brown jacksonJohn kruzelThomas edisonPaul clementUs supreme courtAmgen incRegeneron pharmaceuticals incUs courtNational postPostmedia network incNew york times

U S Supreme Court mulls Amgen bid to revive cholesterol drug patents

Amgen Inc sought to convince the U.S. Supreme Court on Monday to revive patents on its cholesterol-lowering drug Repatha, while rival Sanofi SA urged the justices not to stifle competition for therapies to address a common health risk.

United statesJoe bidenBlake brittainJustice ketanji brown jacksonPaul clementAndrew chungJustice clarence thomasJohn kruzelJeffrey lamkenRegeneron pharmaceuticals incThomson reuters trust principlesUs supreme court onUs courtAmgen incCalifornia based amgenFederal circuit